Medications

Finding a new biomarker and drug target in breast cancer

After examining 398 proteins, a University of Houston College of Pharmacy researcher has found one that is an important biomarker predicting therapy outcome and a potential drug target in estrogen receptor-positive (ER+) ...

page 1 from 13